XML 19 R42.htm IDEA: XBRL DOCUMENT v3.3.0.814
Equity Instruments - Additional Information (Detail)
3 Months Ended 12 Months Ended
Sep. 30, 2015
USD ($)
Stock_Plan
shares
Sep. 30, 2014
USD ($)
Jun. 30, 2015
USD ($)
Jun. 01, 2015
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of stock option plan | Stock_Plan 2      
Shares of common stock reserved for issuance | shares 1,718,828,000,000      
Stock-based compensation expenses $ 68,000 $ 202,000    
Discription of warrant conversion The number of shares of Company stock that these warrants will convert into is equal to 8% of the gross number of shares of the Company stock issuable upon conversion of the Notes issued to investors introduced to the Company by the private placement agents pursuant to the private placement memorandum. The exercise price will be the lowest conversion price per share at which the Notes are converted into Company common stock. The warrants have a term of five years from August 31, 2015.      
Warrants term 5 years      
Stock Options [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expenses     $ 27,000  
Luoxis 2013 [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Unrecognized compensation expense     422,000  
Reversal of share based compensation expense $ 433,000      
2015 Stock Option and Incentive Plan [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Common stock, shares authorized for issuance | shares       10,000,000
Vyrix 2013 [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Unrecognized compensation expense     $ 189,000